Weight-Loss drug trial aims to tame irregular heartbeat after surgery
NCT ID NCT07382024
Summary
This study is testing if a medication called tirzepatide, which helps with weight loss, can also help control a persistent irregular heartbeat (atrial fibrillation) after a corrective heart procedure. It will involve 200 overweight adults who are scheduled for this procedure. Researchers want to see if taking the drug for about 4 months around the time of the procedure reduces how often the irregular heartbeat returns and leads to better health outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Cardiovascular Center
Taipei, 100, Taiwan
Conditions
Explore the condition pages connected to this study.